NCT03605082View on ClinicalTrials.gov

A Study to Test the Safety and Tolerability and Pharmacokinetics of Single Doses of UCB0107 in Healthy Japanese Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 25, 2018

Primary Completion Date

March 11, 2019

Study Completion Date

March 11, 2019

Conditions

Healthy Japanese Volunteers

Interventions

DRUG

UCB0107

"* Pharmaceutical form: solution for infusion~* Route of administration: intravenous use"

OTHER

Placebo

"* Pharmaceutical form: solution for infusion~* Route of administration: intravenous use"

Trial Locations (1)

Unknown

Up0065 001, London

All Listed Sponsors

lead

UCB Biopharma S.P.R.L.

INDUSTRY

NCT03605082 - A Study to Test the Safety and Tolerability and Pharmacokinetics of Single Doses of UCB0107 in Healthy Japanese Subjects | Biotech Hunter | Biotech Hunter